Valeant Pharmaceuticals

Production Technician II

US-FL-Tampa
Job ID
9585
Pos. Category
Operations
Pos. Type
Full Time

Overview

Production Technician II

 

2nd shift, Monday - Friday, 3:00pm-11:30pm in an Aseptic Prep environment. Prior knowledge of, and experience in pharmaceutical manufacturing desired. 

 

Responsible for operating manufacturing equipment ensuring target line rates are met. Performs initial troubleshooting and diagnose operational issues.   Assist other resources when highly technical issues are addressed. 

Responsibilities

1. Responsible for operating manufacturing equipment ensuring target line rates are met. Also responsible to perform line cleaning and clearing, equipment disinfection, predictive maintenance, initial problem assessment for equipment issues, load components during run, documentation, provides operational training to other employees. Ensures production areas cleaned and organized to prevent cross – contamination and product related problems.

 

2. Assist during change over, set up, PMs, minor adjustments and repairs, simple parts design and fabrication, technical training, shutdown planning and projects, generation of work orders and maintenance of spare parts inventory /retrieval and housekeeping of aseptic parts storage area.

 

3. This position requires Aseptic Gowning certification (where applicable). Assume responsibility for the cGMP, ISO, EHS compliance within the respective area. Uses production metrics to drive process improvements and enhance productivity, QC, Visual Inspection, and Line Clearance/LOTO certification needed.

 

4. Completes all documentation accurately Support OpEx initiatives.

 

      

Qualifications

HS Diploma/GED required or AD preferred

 

Ability to operate manufacturing equipment and perform minor troubleshooting and machine adjustments.  Good math and writing skills.  Detail oriented with excellent communication skills and quality conscious. Able to work quickly and under pressure.

Options

Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
Share on your newsfeed